Navigation Links
Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
Date:5/1/2012

096PROPERTY, PLANT AND EQUIPMENT, NET

300,052

297,731GOODWILL

2,560,043

2,558,041OTHER INTANGIBLES, NET

2,416,921

2,504,124OTHER ASSETS

136,784

144,591TOTAL ASSETS

$
,887,210

$
7,292,583LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIES:Accounts payable and accrued expenses

$
972,451

$
993,216Other current liabilities

108,152

128,562Total current liabilities

$
,080,603

$
,121,778DEFERRED INCOME TAXES

573,760

617,677LONG-TERM DEBT, LESS CURRENT PORTION, NET

3,197,015

3,424,329OTHER LIABILITIES

85,947

89,208STOCKHOLDERS' EQUITY:Total Endo Pharmaceuticals Holdings Inc. stockholders' equity

$
,889,133

$
,977,690Noncontrolling interests

60,752

61,901Total stockholders' equity

$
,949,885

$
2,039,591TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$
,887,210

$
7,292,583The following table presents unaudited condensed consolidated statement of cash flow data for the three months ended March 31, 2012 and 2011:20122011OPERATING ACTIVITIES:Consolidated net income,

$
(74,525)

$
8,295Adjustments to reconcile consolidated net income to net cash provided by operating activities:Depreciation and amortization

66,957

47,741Stock-based compensation

14,518

7,416Amortization of debt issuance costs and premium / discount

7,868

5,997Other

20,982

(1,284)Changes in assets and liabilities which provided cash:

(48,862)

2,893Net cash (used in) provided by operating activities

(13,062)

131,058INVESTING ACTIVITIES:Purchases of property, plant and equipment, net

(28,921)

(12,561)Other

(5,000)

(710)Net cash used in investing activ
'/>"/>

SOURCE Endo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Hospira Reports First-Quarter 2012 Results
2. Luminex Corporation Reports First Quarter 2012 Results
3. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
4. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Cepheid Reports 2012 First Quarter Results
11. Sotera Wireless Reports FDA Clearance of ViSi Mobile™ System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that Steven ... and David Haen , Vice President of ... corporate overview at two significant investment conferences in ... industries: the FBR & Co. Second Annual Health ...
(Date:9/1/2015)... 1, 2015 Pressure BioSciences, Inc. (OTCQB: ... the development and sale of broadly enabling, pressure ... worldwide life sciences industry, today announced the publication ... Company,s PCT Platform could play a significant role ... role is based on PCT,s unique ability to ...
(Date:9/1/2015)... , September 1, 2015 ... company, today announces that it has appointed Hilde ... Non-Executive Directors to its Board of Directors, effective immediately. ... years of experience in pharma and biotech and is ... a Sanofi company. Previously her role was Vice President ...
Breaking Medicine Technology:CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5BerGenBio Appoints Non-Executive Directors 2
... Pricing of $500 Million of Senior Notes in Connection with... -- ARDEE, Ireland, Sept. 24 ... ... lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... Misonix, Inc. (Nasdaq: MSON ), a ... technology, which worldwide is used for acute health conditions, ... ended June 30, 2010 financial results on Tuesday, September ... Officer and Richard Zaremba, Senior VP and Chief Financial ...
Cached Medicine Technology:Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 8Misonix Schedules Fourth Quarter and Fiscal 2010 Financial Results Conference Call; September 28, 2010 at 4:30 p.m. Eastern 2
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... ... computing and collaboration, announces Splashtop Business for Remote Support , a solution ... support solution. Unhappy with the escalating renewal prices and inadequate customer services ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... ranked a top-five hospital by U.S. News & World Report, to provide breaking ... , Editorial and marketing groups within OncLive, which provides oncologists resources and ...
(Date:9/1/2015)... ... , ... With former IBMers among its founding members, Inmar has known the ... 35 years ago. A pilot program begun by the company in 2014 has proved ... intent on pursuing careers in these fields. The program is now open to area ...
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data loss prevention ... of endpoint DLP developed specifically for Mac OS. , In June 2015, the company ... and information security professionals had participated. The beta test done by the developer community ...
(Date:9/1/2015)... ... September 01, 2015 , ... Agriculture innovation, urban farming, local food access, ... to be discussed at Seedstock’s 4th Annual Sustainable Agriculture Conference : “Innovation and ... , In addition to keynotes Pierre Sleiman, founder and CEO of Go Green ...
Breaking Medicine News(10 mins):Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 4Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5
... inheritable genes to enable people to produce more ‘perfect’ ... and on being human, warns a leading US science ... out great hope for IGM technology, which offers them ... Disease and schizophrenia on to their children.// ,However, ...
... the risk of pancreatic cancer in both sexes,while moderate ... obese individuals,says Dr. Dominique S. Michaud the head ... National Cancer Institute in Rockville, Maryland and colleagues collected ... 75 years of age, who participated in the Health ...
... popular belief, the heart can actually repair itself by growing new ... researchers in New York and Italy. Dr. Piero Anversa and colleagues ... heart muscle cells called myocytes continued to divide after a heart ... examined the hearts of 13 people who died within a few ...
... patients suffering from Angina may have some new treatment ... Angina, a common cardiovascular disorder affecting millions of people ... by blood vessels too clogged to get oxygen-rich blood ... either medication or for more serious cases, rerouting the ...
... piglets last week could significantly increase the success rate ... research has indicated that rejection of animal cells and ... to the presence of the gene alpha 1,3 galactosyl ... a sugar// to the surface of pig cells, flagging ...
... A new technique to keeping heart arteries flowing easily ... solving a major weakness of the common procedure.Doctors ... - the drug-coated stent. In testing on 30 patients ... percent effective, an accomplishment almost unheard of in medicine.// ...
Cached Medicine News:Health News:Perfect babies boon or a bane? 2Health News:Antibiotic, Gene Therapy Help Treat Angina 2Health News:Antibiotic, Gene Therapy Help Treat Angina 3Health News:Xenotransplantation “breakthrough” 2Health News:A ray of hope in Angioplasty dilemma 2
Inquire...
Calss II Type B2 Biological Safety Cabinet...
External Calibration Only. Built-in RS232 Interface, Shimadzu WindowsDirect communication function. 120/240V A/C adapter....
... Semi-Micro balance. Built-in, motor-driven internal ... Performs Fully Automatic Self-Calibration when temperature ... intervals. Menu-selected weighing parameters, plug-in ... function keypads make this balance series ...
Medicine Products: